Literature DB >> 21632765

Impact of intra- and interspecies variation of occludin on its function as coreceptor for authentic hepatitis C virus particles.

Sandra Ciesek1, Sandra Westhaus, Melanie Wicht, Ilka Wappler, Sylvana Henschen, Christoph Sarrazin, Nabila Hamdi, Ahmed I Abdelaziz, Christian P Strassburg, Heiner Wedemeyer, Michael P Manns, Thomas Pietschmann, Thomas von Hahn.   

Abstract

Hepatitis C virus (HCV) is characterized by a narrow host range and high interindividual variability in the clinical course of infection. Both of these traits are thought to be largely due to genetic variation between species and between individual hosts. The tight junction component occludin (OCLN) is essential for HCV entry into host cells, and the differences between human and murine OCLN are thought to account in part for the inability of HCV to infect mice and hence preclude their use as a convenient small-animal model. This study assesses the impact of genetic variation in OCLN on cell culture-grown HCV (HCVcc) using a newly generated and characterized OCLN(low) subclone of the Huh-7.5 cell line (Huh-7.5 subclone in which endogenous OCLN expression has been downregulated by a short hairpin RNA). We report the frequency of coding nonsynonymous single nucleotide polymorphisms, i.e., polymorphisms resulting in amino acid exchanges, present in the human population and determine their ability to function as HCV (co)receptors. Moreover, we show that murine OCLN can sustain HCVcc entry, albeit with about 5-fold reduced efficiency compared to that of human OCLN. This reduction in efficiency is due solely to two amino acid residues previously identified by others using an HCV pseudoparticle approach. Finally, we use the Huh-7.5/OCLN(low) cell line to show that HCV spread between neighboring cells is strictly dependent on OCLN.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21632765      PMCID: PMC3147936          DOI: 10.1128/JVI.00212-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

Review 1.  Genetics of resistance to HIV infection: Role of co-receptors and co-receptor ligands.

Authors:  Fernando Arenzana-Seisdedos; Marc Parmentier
Journal:  Semin Immunol       Date:  2006-09-15       Impact factor: 11.130

Review 2.  Global epidemiology of hepatitis C virus infection.

Authors:  Colin W Shepard; Lyn Finelli; Miriam J Alter
Journal:  Lancet Infect Dis       Date:  2005-09       Impact factor: 25.071

3.  CD81 is a central regulator of cellular events required for hepatitis C virus infection of human hepatocytes.

Authors:  Michela Brazzoli; Alessia Bianchi; Sara Filippini; Amy Weiner; Qing Zhu; Mariagrazia Pizza; Stefania Crotta
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

4.  Protein kinase A-dependent step(s) in hepatitis C virus entry and infectivity.

Authors:  Michelle J Farquhar; Helen J Harris; Mandy Diskar; Sarah Jones; Christopher J Mee; Søren U Nielsen; Claire L Brimacombe; Sonia Molina; Geoffrey L Toms; Patrick Maurel; John Howl; Friedrich W Herberg; Sven C D van Ijzendoorn; Peter Balfe; Jane A McKeating
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

5.  Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81.

Authors:  Mirjam B Zeisel; George Koutsoudakis; Eva K Schnober; Anita Haberstroh; Hubert E Blum; François-Loïc Cosset; Takaji Wakita; Daniel Jaeck; Michel Doffoel; Cathy Royer; Eric Soulier; Evelyne Schvoerer; Catherine Schuster; Françoise Stoll-Keller; Ralf Bartenschlager; Thomas Pietschmann; Heidi Barth; Thomas F Baumert
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

6.  Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies.

Authors:  Jennifer M Timpe; Zania Stamataki; Adam Jennings; Ke Hu; Michelle J Farquhar; Helen J Harris; Anne Schwarz; Isabelle Desombere; Geert Leroux Roels; Peter Balfe; Jane A McKeating
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

7.  Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry.

Authors:  Matthew J Evans; Thomas von Hahn; Donna M Tscherne; Andrew J Syder; Maryline Panis; Benno Wölk; Theodora Hatziioannou; Jane A McKeating; Paul D Bieniasz; Charles M Rice
Journal:  Nature       Date:  2007-02-25       Impact factor: 49.962

8.  Diverse CD81 proteins support hepatitis C virus infection.

Authors:  Mike Flint; Thomas von Hahn; Jie Zhang; Michelle Farquhar; Christopher T Jones; Peter Balfe; Charles M Rice; Jane A McKeating
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

9.  Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry.

Authors:  Donna M Tscherne; Christopher T Jones; Matthew J Evans; Brett D Lindenbach; Jane A McKeating; Charles M Rice
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

10.  CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells.

Authors:  Jeroen Witteveldt; Matthew J Evans; Julia Bitzegeio; George Koutsoudakis; Ania M Owsianka; Allan G N Angus; Zhen-Yong Keck; Steven K H Foung; Thomas Pietschmann; Charles M Rice; Arvind H Patel
Journal:  J Gen Virol       Date:  2009-01       Impact factor: 3.891

View more
  22 in total

1.  Apolipoprotein E codetermines tissue tropism of hepatitis C virus and is crucial for viral cell-to-cell transmission by contributing to a postenvelopment step of assembly.

Authors:  Kathrin Hueging; Mandy Doepke; Gabrielle Vieyres; Dorothea Bankwitz; Anne Frentzen; Juliane Doerrbecker; Frauke Gumz; Sibylle Haid; Benno Wölk; Lars Kaderali; Thomas Pietschmann
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

2.  Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins.

Authors:  Dorothea Bankwitz; Gabrielle Vieyres; Kathrin Hueging; Julia Bitzegeio; Mandy Doepke; Patrick Chhatwal; Sibylle Haid; Maria Teresa Catanese; Mirjam B Zeisel; Alfredo Nicosia; Thomas F Baumert; Lars Kaderali; Thomas Pietschmann
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

Review 3.  Monoclonal antibodies: Principles and applications of immmunodiagnosis and immunotherapy for hepatitis C virus.

Authors:  Ashraf Tabll; Aymn T Abbas; Sherif El-Kafrawy; Ahmed Wahid
Journal:  World J Hepatol       Date:  2015-10-08

4.  Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency.

Authors:  David A Sheridan; S H Bridge; M M E Crossey; D J Felmlee; H C Thomas; R D G Neely; S D Taylor-Robinson; M F Bassendine
Journal:  Metab Brain Dis       Date:  2014-03-12       Impact factor: 3.584

5.  Monoclonal Antibodies against Occludin Completely Prevented Hepatitis C Virus Infection in a Mouse Model.

Authors:  Yoshimi Shimizu; Yoshitaka Shirasago; Masuo Kondoh; Tetsuro Suzuki; Takaji Wakita; Kentaro Hanada; Kiyohito Yagi; Masayoshi Fukasawa
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

6.  Filovirus Antiviral Activity of Cationic Amphiphilic Drugs Is Associated with Lipophilicity and Ability To Induce Phospholipidosis.

Authors:  Antonia P Gunesch; Francisco J Zapatero-Belinchón; Lukas Pinkert; Eike Steinmann; Michael P Manns; Gisbert Schneider; Thomas Pietschmann; Mark Brönstrup; Thomas von Hahn
Journal:  Antimicrob Agents Chemother       Date:  2020-07-22       Impact factor: 5.191

Review 7.  Evolution of genetic and genomic features unique to the human lineage.

Authors:  Majesta O'Bleness; Veronica B Searles; Ajit Varki; Pascal Gagneux; James M Sikela
Journal:  Nat Rev Genet       Date:  2012-12       Impact factor: 53.242

8.  Different requirements for scavenger receptor class B type I in hepatitis C virus cell-free versus cell-to-cell transmission.

Authors:  Maria Teresa Catanese; Joana Loureiro; Christopher T Jones; Marcus Dorner; Thomas von Hahn; Charles M Rice
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

Review 9.  Hepatitis C virus evasion mechanisms from neutralizing antibodies.

Authors:  Caterina Di Lorenzo; Allan G N Angus; Arvind H Patel
Journal:  Viruses       Date:  2011-11-15       Impact factor: 5.818

Review 10.  Hepatitis C virus infection and tight junction proteins: The ties that bind.

Authors:  Laurent Mailly; Thomas F Baumert
Journal:  Biochim Biophys Acta Biomembr       Date:  2020-04-05       Impact factor: 4.019

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.